Aloin: A natural antitumor anthraquinone glycoside with iron chelating and non-atherogenic activities

Pharmaceutical Biology - Tập 53 Số 1 - Trang 138-146 - 2015
Amr Y. Esmat1, Mahmoud M. Said1, Sally A. Khalil1
1Department of Biochemistry, Faculty of Science, Ain Shams University, Cairo, Egypt

Tóm tắt

Từ khóa


Tài liệu tham khảo

Arola OJ, 2000, Cancer Res, 60, 1789

10.1016/S0300-483X(99)00179-1

Baker FJ. (1985). Introduction to haematology. In: Baker FJ, Silverton RE, Kilshaw D, eds.Introduction to Medical Laboratory Technology. 6th ed. London: Butterworth & Co LTD, 325–6

Bartnikas TB, 2011, Blood, 117, 630, 10.1182/blood-2010-05-287359

British Pharmacopoeia. (1988). Published on the Recommendations of the Medicines Commission Pursuant of the Medicines Act. Vol. 1, London: Her Majesty’s Stationery Office (HMSO), 24–5

Buranakarl C, 2008, Thai J Physiol Sci, 20, 89

Comereski CR, 1994, Toxicol Pathol, 22, 473, 10.1177/019262339402200502

Conklin KA, 2005, Integr Cancer Ther, 4, 110, 10.1177/1534735405276191

Deepa PR, 2005, Toxicology, 211, 77, 10.1016/j.tox.2005.02.009

Doroshow JH, 1983, Cancer Res, 43, 460

Esmat AY, 2005, Cancer Biol Ther, 4, 108, 10.4161/cbt.4.1.1445

Esmat AY, 2012, Drug Dev Res, 73, 154, 10.1002/ddr.21006

10.4161/cbt.5.1.2347

Eteng MU, 2005, Biokemistri, 17, 123

Fahim FA, 1993, J Tumor Marker Oncol, 8, 27

Fahim FA, 1993, J Tumor Marker Oncol, 8, 35

Fahim FA, 1997, Dis Markers, 13, 183

Ferraro C, 2000, Cancer Res, 60, 1901

Friedewald WT, 1972, Clin Chem, 18, 499, 10.1093/clinchem/18.6.499

Herman EH, 1981, Cancer Res, 41, 3436

Hong YM, 2002, Pediatr Res, 51, 249, 10.1203/00006450-200202000-00020

Huang XM, 2003, J Zhejiang Univ Sci, 4, 114, 10.1631/jzus.2003.0114

Injac R, 2008, Pharmacol Rep, 60, 742

10.7326/0003-4819-121-9-199411010-00002

Kwok JC, 2002, Mol Pharmacol, 62, 888, 10.1124/mol.62.4.888

10.1016/S0098-2997(00)00006-6

Maeda A, 1998, Jpn Circ, 62, 505, 10.1253/jcj.62.505

Mansour MA, 1999, Pharmacol Res, 39, 233, 10.1006/phrs.1998.0432

10.1016/j.cellbi.2005.09.001

Metenawy WH, 1996, Cancer Mol Biol, 3, 851

Minotti G, 1999, FASEB J, 13, 199, 10.1096/fasebj.13.2.199

Miranda CJ, 2003, Blood, 102, 2574, 10.1182/blood-2003-03-0869

Misiti F, 2003, Braz J Med Biol Res, 36, 1643, 10.1590/S0100-879X2003001200005

10.1080/15216540252774829

Mukherjee S, 2003, BMC Pharmacol, 20, 3

Nicolay K, 1987, Biochim Biophys Acta – Bioenergetics, 892, 320, 10.1016/0005-2728(87)90236-2

Rajagopalan S, 1988, Cancer Res, 48, 4766

10.1096/fj.07-9574LSF

10.1016/S1734-1140(09)70018-0

10.1124/jpet.106.111468

10.1152/ajpheart.01057.2004

Weiss RB, 1992, Semin Oncol, 670

Wojtacki J, 2000, Med Sci Monit, 6, 411

Zak B, 1954, Am J Clin Pathol, 24, 1307, 10.1093/ajcp/24.11_ts.1307